A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

NCT06609005 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Metastatic Castration Resistant Prostate Cancer

Interventions

DRUG: INV-9956

Sponsor

Shenzhen Ionova Life Sciences Co., Ltd.